|
Name |
Isobutylcyclohexane
|
| Molecular Formula | C10H20 | |
| IUPAC Name* |
2-methylpropylcyclohexane
|
|
| SMILES |
CC(C)CC1CCCCC1
|
|
| InChI |
InChI=1S/C10H20/c1-9(2)8-10-6-4-3-5-7-10/h9-10H,3-8H2,1-2H3
|
|
| InChIKey |
FFROMNOQCNVNIH-UHFFFAOYSA-N
|
|
| Synonyms |
ISOBUTYLCYCLOHEXANE; 1678-98-4; Cyclohexane, isobutyl-; 2-methylpropylcyclohexane; Cyclohexane, (2-methylpropyl)-; ISOBUTYLCYCLOBUTANE; (2-methylpropyl)cyclohexane; NSC-74187; i-Butylcyclohexane; NSC74187; EINECS 216-839-2; WC42CWY8XP; (2-Methyl-propyl)-cyclohexane; DTXSID80168374; ZINC1566661; MFCD00013767; NSC 74187; AKOS024333995; LS-13882; DB-043720; FT-0627370; I0259; D91110
|
|
| CAS | 1678-98-4 | |
| PubChem CID | 15508 | |
| ChEMBL ID | NA |
Chemical Classification: |
|
|
|---|
| Endophyte ID | Endophyte Name | Family | Genus | Taxonomy ID | GenBank ID | Closest GenBank ID | Reference | |
|---|---|---|---|---|---|---|---|---|
| Endophyte ID | Endophyte Name | Family | Genus | Taxonomy ID | GenBank ID | Closest GenBank ID | Reference |
| Bioactivity Name | Target ID | Target Name | Target Type | Target Organism | Target Organism ID | Potency of Bioactivity | Activity Type | Value | Unit | Endophyte ID | Endophyte Name | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Bioactivity Name | Target ID | Target Name | Target Type | Target Organism | Target Organism ID | Potency of Bioactivity | Activity Type | Value | Unit | Endophyte ID | Endophyte Name |
| Molecular Weight: | 140.27 | ALogp: | 4.8 |
| HBD: | 0 | HBA: | 0 |
| Rotatable Bonds: | 2 | Lipinski's rule of five: | Accepted |
| Polar Surface Area: | 0.0 | Aromatic Rings: | 1 |
| Heavy Atoms: | 10 | QED Weighted: | 0.535 |
| Caco-2 Permeability: | -4.338 | MDCK Permeability: | 0.00001480 |
| Pgp-inhibitor: | 0 | Pgp-substrate: | 0.002 |
| Human Intestinal Absorption (HIA): | 0.002 | 20% Bioavailability (F20%): | 0.065 |
| 30% Bioavailability (F30%): | 0.855 |
| Blood-Brain-Barrier Penetration (BBB): | 0.733 | Plasma Protein Binding (PPB): | 95.90% |
| Volume Distribution (VD): | 2.235 | Fu: | 3.05% |
| CYP1A2-inhibitor: | 0.82 | CYP1A2-substrate: | 0.469 |
| CYP2C19-inhibitor: | 0.637 | CYP2C19-substrate: | 0.56 |
| CYP2C9-inhibitor: | 0.573 | CYP2C9-substrate: | 0.946 |
| CYP2D6-inhibitor: | 0.05 | CYP2D6-substrate: | 0.077 |
| CYP3A4-inhibitor: | 0.194 | CYP3A4-substrate: | 0.147 |
| Clearance (CL): | 8.032 | Half-life (T1/2): | 0.172 |
| hERG Blockers: | 0.029 | Human Hepatotoxicity (H-HT): | 0.032 |
| Drug-inuced Liver Injury (DILI): | 0.182 | AMES Toxicity: | 0.006 |
| Rat Oral Acute Toxicity: | 0.023 | Maximum Recommended Daily Dose: | 0.019 |
| Skin Sensitization: | 0.607 | Carcinogencity: | 0.053 |
| Eye Corrosion: | 0.986 | Eye Irritation: | 0.989 |
| Respiratory Toxicity: | 0.307 |
| Similar NPs | Similar Drugs | ||||||
|---|---|---|---|---|---|---|---|
| NPs ID | NPs 2D Structure | Similarity Score | TTD ID | Drug 2D Structure | Similarity Score | ||
| ENC001283 | ![]() |
0.419 | D03DVJ | ![]() |
0.686 | ||
| ENC000644 | ![]() |
0.372 | D08MRN | ![]() |
0.277 | ||
| ENC000540 | ![]() |
0.366 | D04JPJ | ![]() |
0.273 | ||
| ENC001306 | ![]() |
0.356 | D07GRH | ![]() |
0.273 | ||
| ENC001222 | ![]() |
0.348 | D04URO | ![]() |
0.259 | ||
| ENC001167 | ![]() |
0.345 | D0N4PZ | ![]() |
0.250 | ||
| ENC001169 | ![]() |
0.341 | D00SBN | ![]() |
0.239 | ||
| ENC000183 | ![]() |
0.324 | D04CSZ | ![]() |
0.239 | ||
| ENC001712 | ![]() |
0.298 | D08VSI | ![]() |
0.231 | ||
| ENC000170 | ![]() |
0.280 | D07XJM | ![]() |
0.230 | ||